Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models.
Centonze M, Di Conza G, Lahn M, Fabregat I, Dituri F, Gigante I, Serino G, Scialpi R, Carrieri L, Negro R, Pizzuto E, Giannelli G.
Centonze M, et al. Among authors: dituri f.
J Exp Clin Cancer Res. 2023 Aug 8;42(1):197. doi: 10.1186/s13046-023-02780-4.
J Exp Clin Cancer Res. 2023.
PMID: 37550785
Free PMC article.